Antisense antiviral compound and method for treating picornavirus infection

Details for Australian Patent Application No. 2006287530 (hide)

Owner AVI BioPharma, Inc.

Inventors Rijnbrand, Cornelis A.; Iversen, Patrick L.; Weller, Dwight D.; Stein, David A.

Agent FB Rice

Pub. Number AU-A-2006287530

PCT Pub. Number WO2007/030576

Priority 60/800,120 11.05.06 US; 60/715,888 08.09.05 US

Filing date 8 September 2006

Wipo publication date 15 March 2007

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/030576 Priority application(s): WO2007/030576

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006287531-Prodrugs of T3 and T4 with enhanced bioavailability

2006287528-1 , 4 and 1 , 5-disubstituted indole derivatives for use as PPAR active compounds